Results 21 to 30 of about 198,729 (300)

Reduced mechanical efficiency in left-ventricular trabeculae of the spontaneously hypertensive rat. [PDF]

open access: yes, 2014
Long-term systemic arterial hypertension, and its associated compensatory response of left-ventricular hypertrophy, is fatal. This disease leads to cardiac failure and culminates in death.
Barrett, CJ   +6 more
core   +1 more source

LEFT VENTRICULAR HYPERTROPHY; HAEMODIALYSIS PATIENTS

open access: yesThe Professional Medical Journal, 2015
Cardiovascular system diseases are playing the outstanding role in the cause ofmorbidity and mortality in dialysis patients. Left ventricular hypertrophy is one of the universalstructural abnormalities in patients on regular dialysis. Objective: The target of the study wasto search out the frequency of left ventricular hypertrophy in end stage renal ...
Bhagwan Das   +3 more
openaire   +2 more sources

Acute complete heart block in dogs [PDF]

open access: yes, 1955
A study has been conducted immediately and up to 18 days after the surgical production of complete heart block in dogs. Immediately after surgery cardiac output, coronary flow, and mean arterial pressure were reduced in rough proportion to the degree of ...
COHN A. E.   +5 more
core   +1 more source

Left ventricular hypertrophy and insulin resistance in adults from an urban community in The Gambia: cross-sectional study.

open access: yesPLoS ONE, 2014
ObjectiveTo determine the association between left ventricular hypertrophy and insulin resistance in Gambians.DesignCross-sectional study.SettingOutpatient clinics of Royal Victoria Teaching Hospital and Medical Research Council Laboratories in Banjul ...
Bernard Cudjoe Nkum   +3 more
doaj   +1 more source

[OP.2D.05] RELATIONSHIP OF OXIDATIVE STRESS WITH CARDIAC HYPERTROPHY IN HYPERTENSIVE PATIENTS [PDF]

open access: yes, 2016
OBJECTIVE: Left ventricular hypertrophy is common in hypertensive patients. In these subjects increased oxidative stress has been observed. Our aim was to evaluate the association of biomarkers of both oxidative stress and inflammation with markers of ...
Altieri, D.   +6 more
core   +1 more source

Left Ventricular Hypertrophy: Major Risk Factor in Patients with Hypertension: Update and Practical Clinical Applications

open access: yesInternational Journal of Hypertension, 2011
Left ventricular hypertrophy is a maladaptive response to chronic pressure overload and an important risk factor for atrial fibrillation, diastolic heart failure, systolic heart failure, and sudden death in patients with hypertension.
Richard E. Katholi, Daniel M. Couri
doaj   +1 more source

Sostoyanie serdtsa po dannym ekhokardiografiiu lits s ozhireniem, manifestirovavshimv pubertatnyy period

open access: yesОжирение и метаболизм, 2011
47 male patients were included in this study: the group of 17 adolescents with puberty-onset obesity (aged 19,7±0,37 years), the group of 20 adults with puberty-onset obesity (aged 32,25±0,96 years), 10 gender-matched controls (aged 20,8±0,25 years). All

doaj   +1 more source

Aortic calcification and femoral bone density are independently associated with left ventricular mass in patients with chronic kidney disease [PDF]

open access: yes, 2012
Background Vascular calcification and reduced bone density are prevalent in chronic kidney disease and linked to increased cardiovascular risk. The mechanism is unknown.
Chue, Colin D.   +8 more
core   +3 more sources

Left Ventricular Hypertrophy and Hypertension

open access: yesClinical and Experimental Hypertension, 1993
The level of left ventricular (LV) mass as measured by echocardiography or other techniques in hypertensive patients reflects the integrated effects of the level of arterial pressure, the concomitant volume load imposed on the heart, and of alterations in arterial waveform morphology as well as of body size and non-hemodynamic variables.
Devereux RB   +5 more
openaire   +3 more sources

Fibroblast Growth Factor–23 and Cardiac Structure and Function [PDF]

open access: yes, 2014
Background: Fibroblast growth factor–23 (FGF‐23) is a phosphaturic factor previously associated with left ventricular hypertrophy and systolic dysfunction among individuals with chronic kidney disease.
Agarwal, Isha   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy